1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grants2026 Mars Shot Grant Application - Early Detection of Prostate Cancer is sponsored by Society of Nuclear Medicine and Molecular Imaging (SNMMI). Supports nuclear medicine research focused on early detection of prostate cancer for low to intermediate risk cases to improve patient management, survival, and quality of life.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
The Prostate Cancer Foundation and Society of Nuclear Medicine and Molecular Imaging (SNMMI) Collaborate to Advance Prostate Cancer Research | Prostate Cancer Foundation – Collaboration expands PCF’s Young Investigator Award program, which offers career and project support for young physicians and scientists and has contributed a total of $93 million to important prostate cancer research – – SNMMI will co-sponsor a Young Investigator Award focused on advancing important research in nuclear medicine and molecular imaging for prostate cancer – LOS ANGELES, Calif.
and RESTON, Va. , June 25, 2025 – The Prostate Cancer Foundation (PCF) and Society of Nuclear Medicine and Molecular Imaging (SNMMI) announced a collaboration that will provide funding and support for PCF’s 2025 Young Investigator Award program to advance important prostate cancer research among early-career physicians and scientists.
“This collaboration brings together two premier organizations committed to investing in the next generation of scientists that will shape the future of prostate cancer detection and treatment,” said Gina Carithers, PCF’s president and CEO. “We’re proud to continue addressing critical gaps in prostate cancer research through programs like this to drive progress for the millions of men affected by the disease.
We’re especially grateful to our new partner SNMMI for joining us in this mission and helping expand the reach and impact of our work. ” Under the collaboration, the 2025 Young Investigator Award program will include a grant to be awarded to a researcher focused on advancing nuclear medicine and molecular imaging in prostate cancer, a rapidly evolving field poised to transform diagnosis and treatment.
The program has awarded a total of $93 million over three decades to more than 435 researchers who have made important advancements in prostate cancer research and kept the field vibrant with new ideas. Applications for the 2025 Young Investigator Award program will open later this year.
“The Mars Shot Research Fund was established to transform the future of patient care by advancing breakthrough discoveries in nuclear medicine and molecular imaging – already, we’ve seen the immense potential of this field to deliver on that promise,” said Richard Wahl, M. D. , founder and chair of the Mars Shot initiative.
“This is a pivotal moment to continue investing in bold ideas and the talented young researchers committed to meaningfully advancing important new treatment approaches for prostate cancer. Together with PCF, we look forward to supporting today’s young investigators whose work will drive practice-changing advances for men facing this disease,” added Munir Ghesani, M. D.
, Mars Shot co-chair. Nuclear medicine has been central to recent advancements in prostate cancer imaging and treatment, with several approved options that precisely target and treat the disease.
SNMMI launched the Mars Shot Research Fund in 2022 to raise $100 million to support research in the field of nuclear medicine and molecular imaging, focusing on Phase 0 and Phase 1 innovations with the potential to transform the future of medicine. By supporting pioneering research, the Mars Shot is poised to accelerate progress in prostate cancer and beyond.
The Prostate Cancer Foundation (PCF) is the world’s leading philanthropic organization dedicated to funding life-saving prostate cancer research. Founded in 1993 by Mike Milken, PCF has been responsible for raising more than $1 billion in support of cutting-edge research through more than 2,250 research projects at 245 leading cancer centers, with a global footprint spanning 28 countries.
Since PCF’s inception, and through its efforts, patients around the world are living longer, suffering fewer complications, and enjoying better quality of life. PCF is committed to the mission of ending death and suffering from the disease. Learn more at pcf.
org . About the SNMMI Mars Shot Research Fund The ‘ Mars Shot for Nuclear Medicine, Molecular Imaging, and Molecularly Targeted Radiopharmaceutical Therapy ’ is a forward-looking glimpse into the future of nuclear medicine.
Its goal is to provide resources for the translation of visionary nuclear medicine imaging, radiopharmaceutical therapy, and data science research or projects into tools or treatments helping improve the lives of patients.
About the Society of Nuclear Medicine and Molecular Imaging The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine, molecular imaging, and theranostics—precision medicine that allows diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes. For more information, visit www. snmmi.
org . Director of Communications The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes.
Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you. The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes. Manage {vendor_count} vendors
According to the current listing, eligibility includes: Researchers and institutions; open to qualified applicants in nuclear medicine/prostate cancer research. Confirm the full requirements in the official notice before applying.
The current listing shows $100,000. Verify award ceilings, matching requirements, and allowable costs in the official notice.
The published deadline was September 25, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
2026 Mars Shot Grant Application - Early Detection of Prostate Cancer is funded by Society of Nuclear Medicine and Molecular Imaging (SNMMI). Verify program details on the funder's official page before applying.
Applications go through the funder's official portal — the Apply Now link on this page goes there directly.
NASA SSERVI CAN-5 2026 Funding Opportunity (NNH26ZDA016C) is sponsored by NASA Science Mission Directorate and Human Spaceflight Mission Directorate. This Cooperative Agreement Notice invites multi-institutional research teams to compete for major awards supporting lunar science, planetary exploration, NASA's Artemis program, and research that uses the Moon to prepare for future exploration of Mars.
Research Opportunities in Space and Earth Science (ROSES)-2025: C.2 Solar System Science is sponsored by NASA Science Mission Directorate. This program element within ROSES-2025 supports scientific investigations of the solar system, including Mars. Proposals may be submitted at any time, with a final cut-off date of November 12, 2026, for submissions under ROSES-25 rules.
The NIH Common Fund launched PRIMED-AI — Precision Medicine with AI: Integrating Imaging with Multimodal Data — as five coordinated funding opportunities (RFA-RM-27-011 through -015) that build a full pipeline from standards to clinic. Here is how the Playbook, Data-to-Model partnerships, Model-to-Clinic translation, Validation Center, and Logistics Center fit together, what each pays, who is eligible, and how to position before the October 2026 deadlines.
Read articleThe Rural Utilities Service published the ARC Program on September 14, 2026. Same IRA Section 22004 authority that carried the $9.7 billion New ERA program, redirected to nuclear power supply and transmission efficiency. Letters of Interest open October 19 and close November 20.
Read articleDARPA pre-released Release 6 of its FY26 SBIR BAA on September 2, 2026. Five of the seven SBIR topics belong to the Biological Technologies Office, and four of those describe one continuous problem: keeping a casualty alive with no surgeon, no imaging, and no evacuation. Here are the award sizes, the Direct-to-Phase-II gates, and the sequencing DARPA is buying.
Read article